Compare LITE & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITE | GSK |
|---|---|---|
| Founded | 2015 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.9B | 93.3B |
| IPO Year | 2015 | 2013 |
| Metric | LITE | GSK |
|---|---|---|
| Price | $468.37 | $47.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 25 | 9 |
| Target Price | ★ $1,064.75 | $59.12 |
| AVG Volume (30 Days) | ★ 5.2M | 3.3M |
| Earning Date | 11-02-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 3.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.54 | N/A |
| Revenue | ★ $1,247,700,000.00 | N/A |
| Revenue This Year | $121.12 | $3.57 |
| Revenue Next Year | $57.94 | $4.27 |
| P/E Ratio | $151.11 | ★ $32.75 |
| Revenue Growth | ★ 24.57 | N/A |
| 52 Week Low | $266.01 | $45.83 |
| 52 Week High | $1,143.00 | $61.70 |
| Indicator | LITE | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 30.27 | 38.96 |
| Support Level | N/A | $45.83 |
| Resistance Level | $973.13 | $51.66 |
| Average True Range (ATR) | 50.68 | 0.97 |
| MACD | -6.98 | -0.35 |
| Stochastic Oscillator | 1.31 | 3.68 |
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.